In vitro and in vivo modeling has linked constitutive NF-κB activation to many of the hallmarks of cancer, including proliferation and evasion of apoptosis, which can be abrogated by NF-κB inhibition (10, 11). This evidence concerns the gene NFKB1 and cancer.